![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Research Papers
Laboratory of Biochemistry and Molecular Biology, Rockefeller University, New York, New York 10021.
Abstract
The HIV-1 trans-activator Tat increases the rate of transcription from the HIV-1 LTR promoter through the stem-loop-containing TAR RNA. To analyze the mechanisms of Tat action, a cell-free trans-activation system with no preincubation has been developed. Recombinant Tat specifically increased the level of a long runoff transcript but not a promoter-proximal transcript in a TAR-dependent fashion. These observations and the result of pulse-chase experiments support strongly the hypothesis that Tat enhances the ability of RNA polymerase to elongate over longer distances. Increased levels of the purified cellular factor TFIIF, essential for initiation and also implicated in elongation of transcription, obviated trans-activation by Tat by increasing the basal (Tat-independent) activity. However, another elongation factor, ATN/TFIIS, showed synergistic activation with Tat. An antiserum against a recombinant form of the large subunit of TFIIF (RAP 74) preferentially suppressed the activated level of transcription exerted by Tat. We propose the hypothesis that Tat acts as a processivity factor on RNA polymerase II in an analogous manner to TFIIF.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Sanchez-Alvarez, A. C. Goldstrohm, M. A. Garcia-Blanco, and C. Sune Human Transcription Elongation Factor CA150 Localizes to Splicing Factor-Rich Nuclear Speckles and Assembles Transcription and Splicing Components into Complexes through Its Amino and Carboxyl Regions. Mol. Cell. Biol., July 1, 2006; 26(13): 4998 - 5014. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Wong, A. Sharma, S. Awasthi, E. F. Matlock, L. Rogers, C. Van Lint, D. J. Skiest, D. K. Burns, and R. Harrod HIV-1 Tat Interactions with p300 and PCAF Transcriptional Coactivators Inhibit Histone Acetylation and Neurotrophin Signaling through CREB J. Biol. Chem., March 11, 2005; 280(10): 9390 - 9399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Calzado, R. Sancho, and E. Munoz Human Immunodeficiency Virus Type 1 Tat Increases the Expression of Cleavage and Polyadenylation Specificity Factor 73-Kilodalton Subunit Modulating Cellular and Viral Expression J. Virol., July 1, 2004; 78(13): 6846 - 6854. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, J. Li, B. O. Kim, B. S. Pace, and J. J. He HIV-1 Tat Protein-mediated Transactivation of the HIV-1 Long Terminal Repeat Promoter Is Potentiated by a Novel Nuclear Tat-interacting Protein of 110 kDa, Tip110 J. Biol. Chem., June 21, 2002; 277(26): 23854 - 23863. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Bourgeois, Y. K. Kim, M. J. Churcher, M. J. West, and J. Karn Spt5 Cooperates with Human Immunodeficiency Virus Type 1 Tat by Preventing Premature RNA Release at Terminator Sequences Mol. Cell. Biol., February 15, 2002; 22(4): 1079 - 1093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Mischiati, G. Feriotto, M. Borgatti, P. Giacomini, and R. Gambari Characterization of a Major Histocompatibility Complex Class II X-Box-Binding Protein Enhancing Tat-Induced Transcription Directed by the Human Immunodeficiency Virus Type 1 Long Terminal Repeat J. Virol., October 1, 2000; 74(19): 8989 - 9001. [Abstract] [Full Text]
|
|
|
|
|
|
Y. W. Fong and Q. Zhou Relief of Two Built-In Autoinhibitory Mechanisms in P-TEFb Is Required for Assembly of a Multicomponent Transcription Elongation Complex at the Human Immunodeficiency Virus Type 1 Promoter Mol. Cell. Biol., August 15, 2000; 20(16): 5897 - 5907. [Abstract] [Full Text]
|
|
|
|
|
|
A. L. Lehman and M. E. Dahmus The Sensitivity of RNA Polymerase II in Elongation Complexes to C-terminal Domain Phosphatase J. Biol. Chem., May 12, 2000; 275(20): 14923 - 14932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Kashanchi, E. T. Agbottah, C. A. Pise-Masison, R. Mahieux, J. Duvall, A. Kumar, and J. N. Brady Cell Cycle-Regulated Transcription by the Human Immunodeficiency Virus Type 1 Tat Transactivator J. Virol., January 1, 2000; 74(2): 652 - 660. [Abstract] [Full Text]
|
|
|
|
|
|
E. A. Stillman and M. A. Whitt Transcript Initiation and 5'-End Modifications Are Separable Events during Vesicular Stomatitis Virus Transcription J. Virol., September 1, 1999; 73(9): 7199 - 7209. [Abstract] [Full Text]
|
|
|
|
|
|
J. B. Kim, Y. Yamaguchi, T. Wada, H. Handa, and P. A. Sharp Tat-SF1 Protein Associates with RAP30 and Human SPT5 Proteins Mol. Cell. Biol., September 1, 1999; 19(9): 5960 - 5968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kimura, Y. Tao, R. G. Roeder, and P. R. Cook Quantitation of RNA Polymerase II and Its Transcription Factors in an HeLa Cell: Little Soluble Holoenzyme but Significant Amounts of Polymerases Attached to the Nuclear Substructure Mol. Cell. Biol., August 1, 1999; 19(8): 5383 - 5392. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Ramanathan, S. M. Reza, T. M. Young, M. B. Mathews, and T. Pe'ery Human and Rodent Transcription Elongation Factor P-TEFb: Interactions with Human Immunodeficiency Virus Type 1 Tat and Carboxy-Terminal Domain Substrate J. Virol., July 1, 1999; 73(7): 5448 - 5458. [Abstract] [Full Text]
|
|
|
|
|
|
A. M. Trubetskoy, S. A. Okenquist, and J. Lenz R Region Sequences in the Long Terminal Repeat of a Murine Retrovirus Specifically Increase Expression of Unspliced RNAs J. Virol., April 1, 1999; 73(4): 3477 - 3483. [Abstract] [Full Text]
|
|
|
|
 |
|
 I Choudhury, J Wang, S Stein, A Rabson, and M. Leibowitz Translational effects of peptide antagonists of Tat protein of human immunodeficiency virus type 1 J. Gen. Virol., March 1, 1999; 80(3): 777 - 782. [Abstract]
|
|
|
|
|
|
N. F. Marshall, G. K. Dahmus, and M. E. Dahmus Regulation of Carboxyl-terminal Domain Phosphatase by HIV-1 Tat Protein J. Biol. Chem., November 27, 1998; 273(48): 31726 - 31730. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Cupelli, S. A. Okenquist, A. Trubetskoy, and J. Lenz The Secondary Structure of the R Region of a Murine Leukemia Virus Is Important for Stimulation of Long Terminal Repeat-Driven Gene Expression J. Virol., October 1, 1998; 72(10): 7807 - 7814. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. O. Hottiger and G. J. Nabel Interaction of Human Immunodeficiency Virus Type 1 Tat with the Transcriptional Coactivators p300 and CREB Binding Protein J. Virol., October 1, 1998; 72(10): 8252 - 8256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-Y. Li and M. R Green The HIV-1 Tat cellular coactivator Tat-SF1 is a general transcription elongation factor Genes & Dev., October 1, 1998; 12(19): 2992 - 2996. [Abstract] [Full Text]
|
|
|
|
|
|
A. El Kharroubi, G. Piras, R. Zensen, and M. A. Martin Transcriptional Activation of the Integrated Chromatin-Associated Human Immunodeficiency Virus Type 1 Promoter Mol. Cell. Biol., May 1, 1998; 18(5): 2535 - 2544. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. Tan and A. D. Frankel A novel glutamine-RNA interaction identified by screening libraries in mammalian cells PNAS, April 14, 1998; 95(8): 4247 - 4252. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Chun, O. J. Semmes, C. Neuveut, and K.-T. Jeang Modulation of Sp1 Phosphorylation by Human Immunodeficiency Virus Type 1 Tat J. Virol., April 1, 1998; 72(4): 2615 - 2629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Wada, T. Takagi, Y. Yamaguchi, A. Ferdous, T. Imai, S. Hirose, S. Sugimoto, K. Yano, G. A. Hartzog, F. Winston, et al. DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs Genes & Dev., February 1, 1998; 12(3): 343 - 356. [Abstract] [Full Text]
|
|
|
|
|
|
T. P. Cujec, H. Okamoto, K. Fujinaga, J. Meyer, H. Chamberlin, D. O. Morgan, and B. M. Peterlin The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II Genes & Dev., October 15, 1997; 11(20): 2645 - 2657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. F. Garcia-Martinez, D. Ivanov, and R. B. Gaynor Association of Tat with Purified HIV-1 and HIV-2 Transcription Preinitiation Complexes J. Biol. Chem., March 14, 1997; 272(11): 6951 - 6958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Zhou and P. A. Sharp Tat-SF1: Cofactor for Stimulation of Transcriptional Elongation by HIV-1 Tat Science, October 25, 1996; 274(5287): 605 - 610. [Abstract] [Full Text]
|
|
|
|
|
|
A Krumm, L B Hickey, and M Groudine Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation. Genes & Dev., March 1, 1995; 9(5): 559 - 572. [Abstract] [PDF]
|
|
|
|
|
|
J D Fondell, A L Roy, and R G Roeder Unliganded thyroid hormone receptor inhibits formation of a functional preinitiation complex: implications for active repression. Genes & Dev., July 1, 1993; 7(7b): 1400 - 1410. [Abstract] [PDF]
|
|
|
|
|
|
L S Tiley, S J Madore, M H Malim, and B R Cullen The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes & Dev., November 1, 1992; 6(11): 2077 - 2087. [Abstract] [PDF]
|
|
|
|
|
|
A Krumm, T Meulia, M Brunvand, and M Groudine The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes & Dev., November 1, 1992; 6(11): 2201 - 2213. [Abstract] [PDF]
|
|
|
|
|
|
A. F. Holloway, F. Occhiodoro, G. Mittler, M. Meisterernst, and M. F. Shannon Functional Interaction between the HIV Transactivator Tat and the Transcriptional Coactivator PC4 in T Cells J. Biol. Chem., July 7, 2000; 275(28): 21668 - 21677. [Abstract] [Full Text] [PDF]
|
|
